← All stocks

ICU MEDICAL INC/DE

ICUI Net selling
CIK 0000883984 #1419 in the set updated 17 Sep 2026
Bought (120 mo)
$8.96M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.21B
$4.00M on a plan · $205.65M straight out of an exercise
Sold at will
$998.39M
205 of 409 sales
Net
−$1.20B
−$989.43M against sales at will

By person

24 insiders · 430 transactions
61.7×

Vivek Jain holds 61.7 times base salary in stock. $47.88M of shares against $775.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Vivek Jain last reported holding, valued at $171.52, the price Common Stock was last bought or sold at on the open market here, on 3 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
PFIZER INC entity
Director
$722.17M (2)
−$722.17M
0
0.0000%
$0.00
−100.0%
Jain Vivek
Chairman and CEO
$2.47M (2)
$109.96M (68) scheduled
−$107.48M
279,172
1.12%
$47.88M
+474.9%
LOPEZ GEORGE A
Director
$6.33M (6)
$95.70M (156)
−$89.36M
1,193,574
4.77%
$204.72M
−13.9%
Smiths Group International Holdings Ltd entity
Former 10% Owner
$88.04M (1)
−$88.04M
1,670,000
6.68%
$286.43M
−33.2%
SMITHS GROUP PLC entity
Former 10% Owner
$88.04M (1)
−$88.04M
1,670,000
6.68%
$286.43M
−33.2%
BURCAR ALISON D
Vice President and Gen'l Mgr.
$30.77M (25) scheduled
−$30.77M
6,794
0.0272%
$1.17M
+416.7%
Lamb Scott E
Chief Financial Officer,
$20.85M (12) scheduled
−$20.85M
16,274
0.0651%
$2.79M
+250.7%
Voigtlander Christian B.
Chief Operating Officer
$15.25M (24) scheduled
−$15.25M
37,377
0.1495%
$6.41M
+5,389%
SWINNEY ROBERT S
Director
$7.61M (36) scheduled
−$7.61M
20,816
0.0832%
$3.57M
+20.3%
Sanzone Virginia Ruth
VP, General Counsel
$5.62M (27)
−$5.62M
14,604
0.0584%
$2.50M
RIGGS STEVEN
VP Operations
$4.75M (4) scheduled
−$4.75M
3,127
0.0125%
$536.33K
+691.6%
SAUCEDO JOSEPH R
Director
$4.15M (14) scheduled
−$4.15M
0
0.0000%
$0.00
−100.0%
Woolson Daniel
VP, GM-Infusion Capital
$3.52M (9)
−$3.52M
17,062
0.0682%
$2.93M
+867.8%
McCall Thomas D
Vice President and Gen'l Mgr.
$3.37M (3) scheduled
−$3.37M
7,841
0.0314%
$1.34M
+2,389%
Bonnell Brian Michael
Chief Financial Officer
$2.72M (5) scheduled
−$2.72M
56,062
0.2242%
$9.62M
+4,019%
McGrody Kevin J
Chief Accounting Officer
$1.70M (3) scheduled
−$1.70M
4,846
0.0194%
$831.16K
+422.8%
FINNEY ELISHA W
Director
$1.18M (8) scheduled
−$1.18M
4,871
0.0195%
$835.45K
+857.0%
SHERMAN RICHARD MD
Director
$1.04M (5) scheduled
−$1.04M
69,942
0.2797%
$12.00M
+1.1%
Sousa Ben
Chief Information Officer
$887.01K (3)
−$887.01K
3,076
0.0123%
$527.58K
+2,401%
Greenberg David C.
Director
$151.70K (2)
$730.61K (3) scheduled
−$578.91K
9,214
0.0368%
$1.58M
+1,063%
Hoffmeister David F
Director
6,004
0.0240%
$1.03M
Abbey Donald
Director
6,004
0.0240%
$1.03M
+752.8%
Hernandez Laurie
Director
4,862
0.0194%
$833.91K
+4,762%
KENNEDY KOLLEEN T
Director
4,539
0.0182%
$778.51K
Insider
Date
Role
Action
Shares
Price
Amount
Sanzone Virginia Ruth
3 Sep 2026
VP, General Counsel
Sold on a plan
692
$171.52
$118.69K
Sanzone Virginia Ruth
3 Sep 2026
VP, General Counsel
Sold on a plan
724
$169.53
$122.74K
Sanzone Virginia Ruth
3 Sep 2026
VP, General Counsel
Sold on a plan
1,238
$168.44
$208.52K
Sanzone Virginia Ruth
3 Sep 2026
VP, General Counsel
Sold on a plan
2,202
$167.67
$369.20K
Bonnell Brian Michael
1 Sep 2026
Chief Financial Officer
Sold on a plan
6,381
$175.00
$1.12M
Bonnell Brian Michael
31 Aug 2026
Chief Financial Officer
Sold on a plan
1,113
$173.91
$193.57K
Bonnell Brian Michael
31 Aug 2026
Chief Financial Officer
Sold on a plan
4,568
$173.44
$792.29K
Bonnell Brian Michael
31 Aug 2026
Chief Financial Officer
Sold on a plan
1,914
$172.12
$329.44K
Bonnell Brian Michael
31 Aug 2026
Chief Financial Officer
Sold on a plan
1,712
$171.05
$292.84K
Sanzone Virginia Ruth
8 Aug 2024
VP, General Counsel
Sold on a plan
2,050
$144.11
$295.43K
FINNEY ELISHA W
7 Jun 2023
Director
Sold on a plan
194
$190.41
$36.94K
Sanzone Virginia Ruth
11 Apr 2023
VP, General Counsel
Sold on a plan
250
$175.00
$43.75K
Sanzone Virginia Ruth
5 Apr 2023
VP, General Counsel
Sold on a plan
458
$170.00
$77.86K
Showing 250 of 430 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 404
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 13
Sales straight out of an exercise 191
Sales at will 205
Transactions with no price 0
Shares from compensation/vesting 3,329,524
Sales filed before the plan box existed 173
History held since 13 Sep 2016